DSC Advisors’s Amgen AMGN Stock Holding History

DSC Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,000	Closed	-$44K	–	67
2014 Q1	$44K	Buy	+25,000	New	+$3.03M	0.02%	64

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DSC Advisors's AMGN Position: Q3 2022 in Review

DSC Advisors sold out of Amgen (AMGN) in Q3 2022, closing a stake of 899 shares — an estimated $219K sold.

DSC Advisors first reported a position in AMGN in Q2 2013 and held it in 17 quarters. The position peaked at $2.56M in Q3 2016. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

DSC Advisors reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
DSC Advisors sold 899 Amgen shares in Q3 2022, an estimated $219K.
DSC Advisors first reported a position in Amgen in Q2 2013 and held it in 17 quarters.
DSC Advisors's Amgen position peaked at $2.56M in Q3 2016.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on DSC Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.